View more on these topics

Scot Prov enhances CI proposition

Scottish Provident is enhancing its critical illness product range by adding a number of new conditions.

From July 27 Scot Prov will add primary pulmonary hypertension, pulmonary artery graft surgery and structural heart surgery to its self assurance term plan and Pegasus whole of life.

It is also extending its critical illness definition for HIV to include countries outside the EU.

Scot Prov is also removing a number of exclusions from the Pegasus contracts to bring it in line with its self assurance products. The exclusions removed are for claims arising from criminal acts, drug abuse, aviation or hazardous sports and pastime.

An email sent to IFAs says: “It’s a changing world and as a company we need to react by having a range of products that reflect today’s society and help to meet your clients’ requirements.

“We strive to deliver quality protection products that meet your clients’ needs. We also understand that.”



It will never happen to me

Research by Scottish Provident has highlighted once again the need to end the ‘it won’t happen to me’ culture gripping the UK when it comes to their protection needs.

Tories sharpen axe for FSA

The Conservatives have set out their plans for the abolition of the FSA, with prudential powers to be passed to the Bank of England and a new body to regulate advisers.


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers. Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm